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Gangliosides play important biological roles and structural characterization of both the
carbohydrate and the lipid moieties is important. The FT-ICR MS/MS techniques of electron
capture dissociation (ECD), electron detachment dissociation (EDD), and infrared multiphoton
dissociation (IRMPD) provide extensive fragmentation of the protonated and deprotonated
GM1 ganglioside. ECD provides extensive structural information, including identification of
both halves of the ceramide and cleavage of the acetyl moiety of the N-acetylated sugars.
IRMPD provides similar glycan fragmentation but no cleavage of the acetyl moiety. Cleavage
between the fatty acid and the long-chain base of the ceramide moiety is seen in negative-ion
IRMPD but not in positive-ion IRMPD of GM1. Furthermore, this extent of fragmentation
requires a range of laser powers, whereas all information is available from a single ECD
experiment. However, stepwise fragmentation by IRMPD may be used to map the relative
labilities for a series of cleavages. EDD provides the alternative of electron-induced fragmen-
tation for negative ions with extensive fragmentation, but suffers from low efficiency as well
as complication of data analysis by frequent loss of hydrogen atoms. We also show that
analysis of MS/MS data for glycolipids is greatly simplified by classification of product ion
masses to specific regions of the ganglioside based solely on mass defect graphical
analysis. (J Am Soc Mass Spectrom 2005, 16, 752–762) © 2005 American Society for Mass
SpectrometryGangliosides are amphiphilic components local-ized mainly in the outer leaf of cell membranes.The structure of a ganglioside includes a cer-
amide tail (fatty acid N-linked to a sphingosine) of
varying length, saturation, and hydroxylation linked to
a polar carbohydrate head that contains sialic (neura-
minic) acid (Figure 1). The complexity of the carbohy-
drate moiety makes for complex nomenclature; the
current convention has been developed by Svenner-
holm [1]. T h e gangliosides are grouped according to
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doi:10.1016/j.jasms.2005.02.001the number of their sialic acid residues: one (M), two
(D), or three (T). The G1 series contains a tetraose
chain (Gal1 ¡ 3GalNAc1 ¡ 4Gal1 ¡ 4Glc),
whereas G2 glycolipids lack the terminal galactose
and G3 lack the terminal disaccharide (Gal1 ¡
3GalNAc). Therefore, the GM1 ganglioside (Figure 1)
denotes a glycolipid that contains a monosialylated
tetraose oligosaccharide (Gal1 ¡ 3GalNAc1 ¡
4(NeuAc2 ¡ 3)Gal1 ¡ 4Glc1 ¡ 1=Cer).
The biological roles of gangliosides include cell–cell
recognition, contact inhibition, cell adhesion, and tissue
differentiation [2– 4]. Although they are found in all
tissues, they are particularly enriched in the central
nervous system [5]. The carbohydrate portion of the
molecule is directed toward the exterior of the cell and
mediates molecular recognition. The ceramide compo-
sition is cell-specific [6] and provides a hydrophobic
anchor. Ceramide modulates glycolipid function [3,
7–9], perhaps by changing the orientation of the carbo-
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studies of glycolipids should include characterization of
both the lipid and the carbohydrate moieties.
Mass spectrometry has been employed extensively to
study glycolipid structures. Fast atom bombardment
ionization (FAB)-MS [10, 11] and FAB-MS/MS studies
[12] of glycolipids successfully determined the struc-
tures of both the lipid and the carbohydrate portions of
those molecules. However, FAB is a relatively harsh
and insensitive ionization technique, which can cause
extensive precursor ion fragmentation that complicates
mixture analysis. More gentle ionization modes such as
matrix-assisted laser desorption/ionization (MALDI)
and electrospray ionization (ESI) have also been suc-
cessful in the analysis of glycolipids. Juhasz and
Costello studied underivatized and permethylated gan-
gliosides containing one to five sialic acid residues and
different lipid residues by positive- and negative-ion
MALDI-TOF MS [13]. ESI has been employed in the
analysis of gangliosides with different ceramides iso-
lated from white blood cells [14], gangliosides from
complex mixtures obtained from human granulocytes
[15], and to obtain profiles of lipids extracted from
human brain [16, 17].
Fourier transform ion cyclotron resonance (FT-ICR)
mass spectrometry [18, 19] offers high resolving power
and high mass accuracy. Dissociation techniques ap-
plied to FT-ICR MS analysis of biomolecules include
sustained off-resonance collisionally-activated dissocia-
tion [20 –22] (SORI-CAD), infrared multiphoton disso-
ciation [23, 24] (IRMPD), electron capture dissociation
[25, 26] (ECD), and electron detachment dissociation
Figure 1. Structures of the ganglioside GM1. G
that consists of a long-chain amino alcohol, sph
amino group. The polar head is an oligosaccharid
forms, GM1a and GM1b, differing only by the b[27] (EDD). SORI-CAD has been employed to charac-terize lipooligosaccharides from the pathogen Hae-
mophilus influenzae [28] and galactosylceramide from
pig intestine [29]. ECD has been used to localize sites of
O-glycosylation [30] and fatty acid posttranslational
modifications in peptides [31]. Recently, Budnik et al.
combined ECD and CAD in order to characterize chi-
tooligosaccharides from natural and synthetic sources
[32]. We have previously characterized N-linked glyco-
peptides by ECD and IRMPD, demonstrating the
complementarity of structural information obtained
from each dissociation technique [33]. Here, we dem-
onstrate the utility of ECD, EDD and IRMPD for the
structural characterization of the ganglioside, GM1.
The slow heating IRMPD technique provides a vari-
able duration of irradiation which can be employed to
control the extent of secondary fragmentation, thereby
accessing fragmentation pathways not available by sin-
gle-pass CAD external to the ICR cell. The in-cell
dissociation techniques of IRMPD, ECD, and EDD
eliminate the loss of dynamic range, crucial to detection
of single sugars, associated with transfer of externally
generated product ions into the ICR cell and do so
without the pumpdown delay necessary for in-cell
SORI-CAD. For gangliosides, IRMPD produces exten-
sive fragmentation of both positive and negative ions.
The “nonergodic” ECD technique provides a more
random and more extensive distribution of fragmenta-
tion sites. Consequently, ECD produces extensive pri-
mary fragmentation with short duration (milliseconds)
electron irradiation and a better picture of connectivity
between sugars. EDD provides an electron irradiation
alternative for negative ions but more complex frag-
iosides contain a hydrophobic ceramide moiety
sine, which is acylated with a fatty acid on the
t contains sialic acid. GM1 exists as two isomeric
hed versus terminal position of the sialic acid.angl
ingo
e thamentation patterns.
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Sample Preparation
GM1-ganglioside from bovine brain was isolated and
characterized at the Institute of Clinical Neuroscience
[34, 35]. The GM1 sample contained no detectable
amount of the lactotetraose series gangliosides 3=-LM1
and 3=-iso-LM1 [36]. Thin layer chromatography fol-
lowed by chemical detection with resorcinol showed
only the occurrence of GM1a. Due to the detection limit
of the resorcinol reagent, the occurrence of GM1b can’t
be excluded but is 0.2%. Dehydrated samples were
resuspended to a concentration of 100 M in methanol
(Baker, Philipsburg, NJ). For electrospray, samples were
diluted to a concentration of 3 to 5 M in 1:1 water/
methanol with 3% acetic acid for positive ionization or
100% methanol for negative ionization.
Fourier Transform Ion Cyclotron Resonance
Mass Spectrometry
All experiments were performed with a homebuilt 9.4 T
passively shielded ESI-Q-FT-ICR mass spectrometer
Figure 2. (Top) Product positive-ion spectrum f
quadrupole isolated doubly protonated GM1 p
dominant fragment, HexHexNAc= at m/z 366.13
GM1a. All fragment ions are singly charged. (Fi
sialic acid; filled circle, Hexhexose; open squ
symbol denotes loss of H2O). (Symbol with a
Product positive-ion mass spectrum under the s
of IRMPD irradiation has been lengthened to 20
the nonreducing end of HexNAc. Much of the
likely arises from secondary fragmentation of
presence of the GM1b isomer ambiguous.[37] controlled by a modular ICR data acquisitionsystem (MIDAS) [38]. Samples were infused at a flow
rate of 350 nL/min through a 50 m i.d. fused silica
capillary with a mechanically ground tip [39]. For
external ion accumulation [40, 41], ions are held in a
focusing octopole followed by precursor ion mass se-
lection in a quadrupole mass filter and subsequent
accumulation in a linear octopole ion trap (30 s for
positive ions and 5 s for negative ions). Negative ions
are further isolated in the ICR cell by stored waveform
inverse Fourier transform (SWIFT) isolation [42, 43].
The accumulation octopole has been modified for im-
proved ion extraction to include tilted wires that pro-
duce an axial potential gradient [44]. Prior to dissocia-
tion, ions are transferred through an octopole ion guide
to an open-ended cylindrical Penning trap [45].
The instrument configuration for simultaneous access
to both electron and photon irradiation has been previ-
ously described [46]. For IRMPD, an off-axis ( 2.5 de-
grees) CO2 laser (Synrad, Mukilteo, WA) fitted with a
2.5 beam expander irradiates the ion cloud through a
BaF2 window. For ECD and EDD, a 1 cm diameter
dispenser cathode electron source (no. 1109; HeatWave,
Watsonville, CA) is positioned on-axis approximately 73
ing IRMPD (100 ms, 8W) FT-ICR MS/MS of the
sor (30 scans). This spectrum suggests that the
most likely the initial site of fragmentation of
iamond, NeuAc  N-acetylneuraminic acid or
HexNAc  N-acetyl hexosamine). (The prime
gh bar denotes cross-ring cleavage). (Bottom)
onditions as Figure 3a, except that the duration
(30 scans). Anomeric cleavage is seen, except at
tional fragmentation at longer irradiation most
-HexHexNAc= product ion, which makes theollow
recur
9, is
lled d
are,
throu
ame c
0 ms
addi
the Mcm behind the ICR cell. Normally the molybdenum grid
755J Am Soc Mass Spectrom 2005, 16, 752–762 IRMPD, ECD, AND EDD OF GLYCOSPHINGOLIPIDS(80% transmission) is held at200 V to impede the flow of
electrons. For ECD (of positive ions) the cathode voltage is
biased to 5 V, the grid to 5 V, and the ICR cell trap
plates to10 V. Following ECD, a 1ms event in which the
trap plates are dropped to 2 V, grid to 5 V, and
cathode to10 V is used to purge any remaining electrons
Figure 3. Product negative-ion mass spectru
deprotonated GM1 precursor (100 scans). Fragm
doubly protonated form. In contrast to IRMPD
cleavage within the ceramide moiety associated
belong only to GM1a are shown in red; those w
GM1b as a minor component is evident from the
to a loss of the disaccharide HexNeuAc= from th
Table 1. Molecular assignments and neural masses of product i
(z) Measured m/z  Precursor Assig
(1) 204.0864 1342.7976 HexNAc= or A
(1) 274.0919 1272.7921 NeuAc
(1) 292.1024 1254.7816 NeuAc=
(1) 366.1392 1180.7448 HexHexNAc=
(1) 530.5294 1016.3546 ceramide
(1) 548.5399 998.3441 cermide=
(1) 566.5506 980.3334 ceramide
(1) 710.5933 836.2907 M-HexHexNA
(1) 728.6042 818.2798 M-(HexHexNA
(1) 872.6475 674.2365 M-HexHexNA
(1) 890.6572 656.2268 M-(HexHexNA
(1) 1163.7429 383.1411 M-HexHexNA
(1) 1181.7549 365.1291 M-(HexHexNA
(1) 1237.7798 309.1042 M-NeuAc
(1) 1255.7867 291.0973 M-NeuAc=
(1) 1325.7984 221.0856 M-A1 of NeuA
(1) 1528.8685 18.0155 [M  H]-H2O
(1) 1546.8825 0.0015 [M  H]452.141. (All fragment ions are singly charged.)from the ICR cell. For EDD (of negative ions) the cathode
voltage is biased to8 V, the grid to200 V and the trap
plates to 5 V. Following dissociation ions undergo
frequency-sweep excitation (72 to 960 kHz at 150 Hz/s,
m/z 150–2000) and broadband detection (512 Kword data
points). The digitized time domain transient signal is
llowing IRMPD (200 ms, 14 W) of doubly
tion is more extensive than for IRMPD of the
the protonated form, these fragments include
h loss of the fatty acid. Product ions that can
suggest GM1b are shown in blue. Presence of a
ent ion peak atm/z 1091.722 which corresponds
ecursor and its disaccharide complement at m/z
f GM1 in IRMPD of the doubly protonated precursor ion
nt Formula
Calculated
m/z Error (ppm)
NeuAc= C8H13NO5 204.0867 1.2
C11H15NO7 274.0921 0.5
C11H17NO8 292.1027 0.9
C14H23NO10 366.1395 0.7
C36H67NO 530.5295 0.1
C36H69NO2 548.5401 0.3
C36H71NO3 566.5507 0.1
NeuAc C42H79NO7 710.5929 0.6
xNeuAc)= C42H81NO8 728.6035 1.0
Ac C48H89NO12 872.6457 2.1
uAc)= C48H91NO13 890.6563 1.1
C59H106N2O20 1163.7412 1.5
C59H108N2O21 1181.7517 2.8
C62H112N2O22 1237.7779 1.6
C62H114N2O23 1255.7884 1.3
C65H116N2O25 1325.7939 3.4
C73H129N3O30 1528.8731 3.0
C73H131N3O31 1546.8838 0.8m fo
enta
of
wit
hich
fragm
e prons o
nme
1 of
cHex
cHe
cNeu
cNe
c
c)=
c
756 McFARLAND ET AL. J Am Soc Mass Spectrom 2005, 16, 752–762Hanning apodized and one zero-fill applied prior to fast
Fourier transformation to yield a magnitude mode fre-
quency spectrum that is converted to a mass-to charge
ratio spectrum with a two-term calibration equation [47,
48]. All precursor ions are doubly protonated or doubly
deprotonated. All product ions are singly protonated or
singly deprotonated. All spectra are externally calibrated
with Agilent ESI tuning mix ions (m/z 622.02895,
922.00979, and 1521.97146, Agilent Technologies, Wil-
mington, DE). Molecular formulas were derived from
calibrated masses with an in-house molecular formula
calculator and theoretical masses were calculated with
Isopro 3.1 (MS/MS software, http://members.aol.com/
msmssoft/). All MS and MS/MS assignments have a
mass accuracy of 3 ppm or better.
Results and Discussion
GM1 was analyzed as both positive and negative ions
with a 9.4 T ESI-Q-FT-ICR mass spectrometer. GM1
exists as two major species in brain differing by cer-
amide chain lengths, d18:1/C18:0 and d20:1/C18:0 [49].
All present experiments derive from the quadrupole-
isolated d18:1/C18:0 form.
Infrared Multiphoton Dissociation (IRMPD)
of Positive Ions
Figure 2 (top) shows the product ion spectrum ob-
Table 2. Molecular assignments and neutral masses of product
(z) Measured m/z  Precursor Assign
(1) 161.0453 1383.8240 hexose=
(1) 179.0558 1365.8135 hexose
(1) 202.0718 1342.7975 HexNAc= or A
(1) 283.2638 1261.6055 sphingosine-N
(1) 290.0877 1254.7816 NeuAc=
(1) 308.0983 1236.7710 NeuAc
(1) 382.1348 1162.7345 HexHexNAc
(1) 452.1405 1092.7288 HexNeuAc=
(1) 528.5145 1016.3548 ceramide
(1) 546.5252 998.3441 ceramide=
(1) 564.5356 980.3337 ceramide
(1) 708.5784 836.2909 M-HexHexNA
(1) 726.5889 818.2804 M-HexHexNA
(2) 771.9308 0.0004 [M-2H]2
(1) 817.2734 727.5959 HexHexNAcH
(1) 835.2841 709.5852 HexHexNAcH
(1) 888.6421 656.2272 M-(HexHexNA
(1) 979.3257 565.5436 glycan=
(1) 997.3375 547.5318 glycan
(1) 1073.7081 471.1612 M-(HexNeuAc
(1) 1091.7216 453.1477 M-(HexNeuAc
(1) 1161.7301 383.1392 M-(HexHexNA
(1) 1179.7367 365.1326 M-(HexHexNA
(1) 1253.7756 291.0937 M-NeuAc=
(1) 1260.5987 284.2706 M-(fattyacid-H
(1) 1323.782 221.0873 M-A1 of NeuA
(1) 1364.8076 180.0617 M-Gal
(1) 1382.8166 162.0527 M-Gal=tained from IRMPD (100 ms, 8W) FT-ICR MS/MS ofquadrupole-isolated doubly protonated GM1 d18:1/
C18:0 precursor ions (30 scans). IRMPD is a slow
heating technique and therefore cleaves the weakest
bonds first [50]. The irradiation period of 100 ms
represents the initial threshold for fragmentation;
loss of the disaccharide HexHexNAc= (=  H2O)
thus identifies the initial cleavage site. No fragments
corresponding to terminal NeuAcHex and NeuA-
cHexHexNac could be detected in this spectrum. This
result confirms the GM1a isomer as the principal
species. Because only the most labile bonds are
broken, one learns only a little about the carbohy-
drate and nothing about the ceramide portion of the
ganglioside.
Fortunately, the primary IRMPD fragment ions
remain trapped in the path of the IR beam, and may
thus continue to absorb IR power until secondary
fragmentation (of stronger bonds) occurs. The extent
of fragmentation may thus be adjusted by varying the
duration of IR irradiation. Figure 2 (bottom) (Table 1)
shows the FT-ICR MS/MS spectrum for a longer
IR-irradiation period (200 ms, 8 W) under otherwise
identical conditions (30 scans). Much more extensive
information results from further fragmentation of the
M-HexHexNAc= product ions, including anomeric
cleavage between adjacent sugars, except at the non-
reducing end of HexNAc. Fragmentation of both
positive and negative ions produces a neutral loss
of GM1 in IRMPD of the doubly deprotonated precursor ion
t Formula
Calculated
m/z Error (ppm)
C6H10O5 161.0456 1.6
C6H12O6 179.0562 2.0
NeuAc= C8H13NO5 202.0722 1.7
C18H36O2 283.2643 1.6
C11H17NO8 290.0882 1.6
C11H19NO9 308.0988 1.5
C14H25NO11 382.1356 2.0
C17H27NO13 452.1410 1.0
C36H67NO 528.5150 0.9
C36H69NO2 546.5257 0.8
C36H71NO3 564.5362 1.0
NeuAc C42H79NO7 708.5784 0.1
NeuAc= C42H81NO8 726.5890 0.1
C73H131N3O31 771.9310 0.3
uAc= C31H50N2O23 817.2731 0.4
uAc C31H52N2O24 835.2837 0.5
uAc=) C48H91NO13 888.6418 0.4
C37H60N2O28 979.3259 0.2
C37H62N2O29 997.3365 1.1
C56H102N2O17 1073.7106 2.3
C56H104N2O18 1091.7211 0.5
C59H106N2O20 1161.7267 3.0
C59H108N2O21 1179.7372 0.4
C62H114N2O23 1253.7739 1.4
O C55H95N3O29 1260.5978 0.8
C65H116N2O25 1323.7794 2.0
C67H119N3O25 1364.8059 1.3
C67H121N3O26 1382.8165 0.1ions
men
1 of
cHex
cHex
exNe
exNe
cNe
)
=)
c)
c=)
)-H2
cequal to the mass of HexNAc as well as the corre-
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arise from cross-ring cleavage of sialic acid, corre-
sponding to the loss of 221.1 Da and the retention of
pyruvic acid. Particularly important for glycosphingolip-
ids is the presence of diagnostic peaks at m/z 566.551 and
548.540 corresponding to the intact ceramide and cer-
amide minus H2O portion of the molecule.
Infrared Multiphoton Dissociation (IRMPD)
of Negative Ions
The same GM1 sample was subjected to negative
ionization. Figure 3 (Table 2) shows the IRMPD
MS/MS spectrum of the doubly deprotonated d18:1/
C18:0 GM1 precursor (200 ms, 14 W, 100 scans). The
IRMPD negative-ion fragmentation of GM1 is more
extensive than for positive ions and offers more
detailed data for structural analysis of GM1, includ-
ing cleavage at all glycosidic bonds. This is the only
case in which we observe the fragment corresponding
to the hexose single residue mass of 162.053 Da. Also
helpful is the retention of multiple polysaccharides in
the fragment ions, in particular the entire glycan.
Fragments corresponding to the ceramide are more
pronounced than for the protonated precursor and
they appear as a diagnostic trio of peaks; ceramide as
well as a single and double water loss. Secondary
Figure 4. Product positive-ion mass spectru
protonated GM1 (50 scans). ECD gives the mo
yielding product ions identifying both the fatty
ECD also provides complementary polysacchari
ion peaks labeled in green represent fragments s
confirming the presence of N-acetylated sugar
labeled with stars indicate an additional peak co
of sialic acid.fragmentation of the ceramide separates the fatty acidfrom the long-chain base that appears as the sphin-
gosine-N fragment (see also Figure 6). Fragmentation
within the ceramide moiety was not seen for IRMPD
of the doubly protonated GM1, although fragmenta-
tion within the ceramide was seen by positive-ion
IRMPD of sulfatides with the same instrument (data
not shown).
GM1 exists as two isomeric forms, GM1a and
GM1b (also called cis-GM1 [1]), which differ only by
the branched versus terminal position of the sialic
acid (Figure 1). Although samples were thought to
contain only GM1a, the spectra suggest that a small
amount of the GM1b isomer is also present. Frag-
ments that can derive only from GM1a are labeled in
red, those from GM1b in blue, and those that could
come from either in black. As in the positive-ion
spectrum, Figure 3 shows a peak at m/z 888.642
corresponding to M-HexHexNAcNeuAc= and sug-
gesting the presence of the GM1b isomer. However,
as there is no corresponding trisaccharide peak ob-
served in either spectrum, this fragment could be the
result of secondary fragmentation. More conclusive
to the presence of a less abundant GM1b component
is the fragment ion peak at m/z 1091.7216 Da which
corresponds to a loss of the disaccharide HexNeuAc=
from the precursor and, importantly, its disaccharide
llowing ECD (50 ms irradiation) of doubly
tensive fragmentation of the present methods,
and sphingosine chains of the ceramide region.
agment ions for all M-sugar fragments. Product
nly by ECD, including loss of the acetyl moiety,
fragment ions are singly charged. Fragments
onding to a loss of 2H associated with the lossm fo
st ex
acid
de fr
een o
s. All
rrespcomplement at m/z 452.141 (Figure 3).
ross-
758 McFARLAND ET AL. J Am Soc Mass Spectrom 2005, 16, 752–762Electron Capture Dissociation (ECD)
of Positive Ions
The ECD mass spectrum offers further and more con-
vincing diagnostic evidence for the GM1 structure (and
the presence of a minor GM1b component). Figure 4
shows the product ion spectrum obtained from ECD (50
ms irradiation) of doubly protonated d18:1/C18:0 GM1
(50 scans). Fragmentation of glycopeptides by ECD is
dominated by cleavage along the peptide backbone,
with little to no cleavage of the glycan [30, 33]. In
contrast, ECD of gangliosides produces extensive frag-
mentation throughout the glycan moiety, including
cleavage at all glycosidic bonds except for the terminal
hexose of GM1a. In fact, in one ECD spectrum we
generate fragments which provide information on ev-
ery region of the ganglioside. ECD produces the diag-
nostic trio of peaks corresponding to the ceramide
portion of the precursor, as well as product ions iden-
tifying both the fatty acid and the sphingosine chains of
the ceramide region. Assignment of the fragments cor-
responding to fragmentation within the ceramide, as
well as loss of the fatty acidNH2 from the parent (not
labeled), are confirmed by mass defect (see Figure 7).
Unique to ECD is the noticeable loss of the acetyl moiety,
confirming the presence of an N-acetylated sugar [32].
Much more frequently, both ECD and EDD (see below)
Figure 5. Product negative-ion mass spectrum f
quadrupole- and SWIFT-isolated doubly deprot
fragments also show a loss of H· (not labeled
suggests multiple neutral losses or cross-ring cle
alternative to IRMPD but suffers from low effi
prevalent loss of H· combined with the 2H loss a
EDD for structural analysis of gangliosides, at
technique. (Symbol with a through bar denote cyield fragment ions associated with the loss of sialic acidas well as a second set of fragment ions corresponding to
a loss of 2H (labeled by stars in Figure 5) [10, 12].
Similar to IRMPD, ECD confirms the presence of the
GM1a isomer based on complementary fragment ions
corresponding to the presence and loss of the disaccharide
HexHexNAc= at m/z 366.139 and 1181.752 (Table 3). We
also see confirmation of GM1b by the presence of the M
HexNeuAc and its disaccharide complement, as in nega-
tive-ion IRMPD. However, ECD offers more conclusive
evidence for the presence of GM1b. We see the same loss
of the trisaccharide HexHexNAcNeuAc as for IRMPD,
again suggesting the presence of GM1b. But with ECDwe
also see the all important complementary fragment ion
corresponding to the trisaccharide at m/z 675.245. In fact,
we see complementary polysaccharide fragments for all
sugar losses, offering much more conclusive evidence for
the presence of two isomeric structures, the primary
component GM1a and the much less abundant GM1b.
It is intriguing to note that the presence of so many
complementary ion pairs may suggest that ECD can
provide extensive coverage of the glycan region of gan-
gliosides by primary fragmentation, retaining information
on the connectivity of the sugars. Because ECD fragments
are likely generated before the deposited energy is redis-
tributed [25], ECD shows little to no preference for cleav-
age of labile bonds in peptides and proteins [51]. In
ing EDD (1 s irradiation) FT-ICR MS/MS of the
d GM1 precursor (100 scans). Most water loss
ss defect graphical analysis (not shown) also
es not yet identified. EDD offers a negative-ion
y of precursor to product ion conversion. The
ated with the presence of sialic acid complicates
until more is understood of this fragmentation
ring cleavage).ollow
onate
). Ma
avag
cienc
ssoci
leastaddition, secondary capture of electrons by the singly
759J Am Soc Mass Spectrom 2005, 16, 752–762 IRMPD, ECD, AND EDD OF GLYCOSPHINGOLIPIDScharged product ions of GM1 would result in neutraliza-
tion, so that any subsequent fragmentation will not be
observable by mass spectrometry. However, multiple
peptide backbone cleavages in cyclic peptides [52] and
secondary side chain cleavages in linear peptides [53]
have both been shown to be induced by capture of a single
electron. Further investigation and a wider range of pure
gangliosides will be required to establish whether capture
of an electron results in single or multiple cleavages
within the glycan.
Electron Detachment Dissociation (EDD)
of Negative Ions
Figure 5 (see also Table 4) shows the negative product ion
mass spectrum obtained by EDD (1 s electron irradiation)
FT-ICR MS/MS of the quadrupole- and SWIFT-isolated
doubly deprotonated d18:1/C18:0 GM1 precursor (100
scans). Little is known of the actual mechanism for EDD
fragmentation, although it is postulated to involve elec-
tron-hole recombination [27]. Moreover, the lack of charge
mediation in negative-ion fragmentation makes interpre-
tation of the spectra difficult. As for negative-ion IRMPD,
cleavage is seen between all sugars. However, no cleavage
Table 3. Molecular assignments and neutral masses of product
(z) Measured m/z  Precursor Assig
(1) 204.0863 1342.7977 HexNAc= or A1 o
(1) 264.2682 1282.6158 sphingosine
(1) 274.0917 1272.7923 NeuAc
(1) 284.2943 1262.5897 fatty acid  NH2
(1) 292.1023 1254.7817 NeuAc=
(1) 366.1389 1180.7451 HexHexNAc=
(1) 454.1549 1092.7291 HexNeuAc=
(1) 530.5286 1016.3554 ceramide & -H
(1) 548.5392 998.3448 ceramide= & -2H
(1) 566.5498 980.3342 ceramide
(1) 675.2449 871.6391 HexHexNAcNeu
(1) 710.5924 836.2916 M-(HexHexNAcH
(1) 728.6029 818.2811 M-(HexHexNacH
(2) 773.9451 0.0011 [M  2H]2
(1) 819.2853 727.5987 HexHexNAcHex
(1) 856.6499 690.2341 M-(HexHexNAcN
(1) 872.6448 674.2392 M-(HexHexNAcN
(1) 890.6561 656.2279 M-(HexHexNAcN
(1) 981.3394 565.5446 glycan= &-H
(1) 999.3502 547.5338 glycan
(1) 1075.7258 471.1582 M-(HexNeuAc)
(1) 1163.7414 383.1426 M-(HexHexNAc)
(1) 1181.7522 365.1318 M-(HexHexNAc)
(1) 1235.7618 311.1222 M-(NeuAc)-2H
(1) 1237.7751 309.1089 M-NeuAc
(1) 1253.7729 293.1111 M-(NeuAc)=-2H
(1) 1255.7831 291.1009 M-NeuAc=
(1) 1262.6091 284.2749 M-(fatty acid 
(1) 1325.7949 221.0891 M-HexNAc or M
(1) 1504.8743 42.0097 M-C2H2O (-acety
(1) 1528.8734 18.0106 [M  H] - H2O
(1) 1546.8853 0.0013 [M  H]
(1) 1547.8869 0.0044 [M  2H  e]●is seen within the ceramide. In addition, most water lossfragments also show a loss of H· (not shown). Frequent
loss of H· combined with the 2H loss associated with the
loss of sialic acid makes assignment of novel fragmenta-
tion difficult. Several relatively abundant fragment ions
remain unassigned. EDD does offer a negative-ion alter-
native to IRMPD but its low efficiency of precursor to
product ion conversion combined with the ambiguity in
novel assignments makes this technique difficult for struc-
tural analysis of gangliosides, at least until more is under-
stood of this fragmentation technique. EDD of nonsialy-
lated glycosphingolipids, which would eliminate the
confusion of a loss of two hydrogens could prove more
useful in deciphering novel fragmentation patterns such
as possible cross-ring cleavages.
Mass Defect Analysis
Many species in the mass spectra of Figures 2–5 may be
assigned by matching the accurately measured (to 1
ppm) mass to a putative elemental composition, CcHhN-
nOo, corresponding to conventional bond cleavages (e.g.,
peptidic, glycosidic). Assignment of species correspond-
ing to other cleavages, e.g., cross-ring, with the simulta-
neous complication of losses of H·, 2H, H2O, etc. is much
of GM1 in ECD of the doubly protonated precursor ion
nt Formula
Calculated
m/z error (ppm)
uAc C8H13NO5 204.0867 1.7
C18H33N 264.2686 1.3
C11H15NO7 274.0921 1.3
C18H37NO 284.2948 1.6
C11H17NO8 292.1027 1.2
C14H23NO10 366.1395 1.5
C17H27NO13 454.1555 1.2
C36H67NO 530.5295 1.6
C36H69NO2 548.5401 1.6
C36H71NO3 566.5507 1.5
C25H42N2O19 675.2455 0.8
euAc) &-2H C42H79NO7 710.5930 0.8
uAc)= & -2H C42H81NO8 728.6036 0.9
C73H131N3O31 773.9456 0.6
c= &-H C31H50N2O23 819.2877 2.9
c)-O & -2H C48H89NO11 856.6509 1.1
c) &-2H C48H89NO12 872.6458 1.1
c)= &-2H C48H91NO13 890.6564 0.3
C37H60N2O28 981.3405 1.1
C37H62N2O29 999.3511 0.9
C56H102N2O17 1075.7252 0.6
C59H106N2O20 1163.7412 0.2
C59H108N2O21 1181.7518 0.4
C62H110N2O22 1235.7623 0.4
C62H112N2O22 1237.7780 2.3
C62H112N2O23 1253.7729 0.04
C62H114N2O23 1255.7886 4.3
C55H95N3O29 1262.6124 2.6
f NeuAc C65H116N2O25 1325.7941 0.6
C71H129N3O30 1504.8734 0.6
C73H129N3O30 1528.8734 0.03
C73H131N3O31 1546.8840 0.9
C73H131N3O31 1547.8917 3.1ions
nme
f Ne
*
Ac
exN
exNe
NeuA
euA
euA
euA
=
NH2)
-A1 o
l)more difficult. However, it is possible to distinguish lipid
760 McFARLAND ET AL. J Am Soc Mass Spectrom 2005, 16, 752–762from oligosaccharide from liposaccharide, and even deter-
mine the number of fatty acid chains and/or number of
sugars, based simply on differences in fractional mass (i.e.,
the decimal portion of the exact mass). Mass defect graph-
ical analysis [54 –56] is particularly successful for struc-
tural analysis of glycolipids because of the significant
compositional differences between sugars versus lipids
Figure 6. Mass defect graphical analysis of the IRMPD of doubly
deprotonated GM1 spectra shown in Figure 3. The high mass
resolving power of FT-ICRMS/MS allows localization of product ion
masses to specific regions of the ganglioside based solely on mass
defect graphical analysis. Product ion masses separate themselves
into distinct lines, with those containing lipid eventually intercepting
the theoretical hydrocarbon line. This graph shows the existence of a
significant loss of hydrocarbon chain (most likely fatty acid) followed
by a series of sugar losses from the remaining long-chain base, a
series of secondary fragmentation that would not have been easy to
Table 4. Molecular assignments and neutral masses of product
(z) measured m/z  precursor assign
(1) 290.0876 1254.7819 NeuAc-H2O
(1) 308.0982 1236.7713 NeuAc and Ne
(1) 450.1246 1094.7449 HexNeuAc=-2H
(1) 564.5353 980.3342 ceramide
(1) 655.2196 889.6499 HexHexNAcNe
(1) 706.2404 838.6291 HexHexNAcHe
(1) 726.5886 818.2809 M-(HexHexNA
(2) 771.9300 0.0022 [M-2H]2
(1) 833.2679 711.6016 HexHexNAcNe
(1) 978.3177 566.5518 glycan=-H●
(1) 995.3209 549.5486 glycan-2H
(1) 997.3359 547.5336 glycan
(1) 1091.7222 453.1473 M-(HexNeuAc)
(1) 1161.7244 383.1451 M-(HexHexNA
(1) 1253.7738 291.0957 M-(NeuAc)= &-
(1) 1324.7871 220.0824 M-(HexNAc) 
(1) 1382.8138 162.0557 M-(Hex-H2O)
(1) 1380.7992 164.0703 M-(Hex-O)
(1) 1482.8345 62.0350 M-HexA2
(1) 1542.8534 1.0088 [M-3H-2e]
(1) 1543.8606 0.0016 [M-2H-e]●pick out by product ion masses alone.greatly simplifies assignment of MS-MS data. Figure 6 and
Figure 7 illustrate the ease with which product ion masses
can be assigned to specific regions of the ganglioside.
Product ionmasses separate themselves into distinct lines,
with those containing lipid eventually intercepting the
theoretical hydrocarbon line. Graphical analysis of prod-
uct ion data for the negative-ion IRMPD of GM1 (Figure 6)
makes evident the existence of a significant loss of hydro-
carbon chain (most likely loss of fatty acid) followed by a
series of secondary sugar losses from the remaining long-
chain base, a series that would not have been easy to pick
out from product ion masses alone. Trends in fragmenta-
Figure 7. Mass defect graphical analysis of the ECD spectra
shown in Figure 4. Assignment of the fragments corresponding to
cleavage on either side of the nitrogen of the ceramide is con-
firmed, as well as identification of the presence of a complimen-
of GM1 in EDD of the doubly deprotonated precursor ion
formula
calc’d
m/z error (ppm)
C11H17NO8 290.0882 1.9
H● C11H19NO9 308.0988 1.8
C17H25NO13 450.1253 1.6
C36H71NO3 564.5362 1.5
& -H● C25H40N2O18 655.2204 1.1
C26H45NO21 706.2412 1.1
NeuAc)= C42H81NO8 726.5891 0.6
C73H131N3O31 771.9311 1.4
2H C31H50N2O24 833.2682 0.3
C37H59N2O28 978.3182 0.5
C37H60N2O29 995.3210 0.1
C37H62N2O29 997.3366 0.7
C56H104N2O18 1091.7212 1.0
C59H106N2O20 1161.7267 2.0
C62H114N2O23 1253.7740 0.1
C65H117N2O25 1324.7873 0.1
C67H121N3O26 1382.8166 2.0
C67H119N3O26 1380.8010 1.3
C71H125N3O29 1482.8327 1.2
C73H130N3O31 1542.8538 0.3
C73H131N3O31 1543.8617 0.7ions
ment
uAc-
uAc=
xHex
cHex
uAc-
=
c)
H●
Htary M  (loss of the fatty acid  NH2) (not labeled in Figure 4).
761J Am Soc Mass Spectrom 2005, 16, 752–762 IRMPD, ECD, AND EDD OF GLYCOSPHINGOLIPIDStion patterns, such as the significant secondary fragmen-
tation of IRMPD, are easily visualized and provide addi-
tional insight into the pattern of fragmentation. Similarly,
mass defect graphical analysis for ECD of GM1 (Figure 7)
supports the possibility that there may be little to no
secondary fragmentation within the glycan following ini-
tial electron capture. Here we see a similar loss of a
hydrocarbon chain as well as its compliment but no
intermediate sequence of sugar loss, suggestion primary
fragmentation as the origin of sugar fragments. Graphical
analysis of EDD fragment ion data (not shown) shows
only a series of sugar loss from the parent and a series of
sugars. All unassigned peaks fall into one of these two
lines, suggesting cross-ring cleavage or extensive neutral
loss for the yet unassigned fragments.
Conclusions
The FT-ICR MS/MS techniques of infrared multiphoton
dissociation, electron capture dissociation, and electron
detachment dissociation produce extensive fragmentation
of the protonated and deprotonated GM1 ganglioside.
ECD offers the most promise because its extensive frag-
mentation, as well as the possibility of little to no second-
ary fragmentation, allows for a more definitive determi-
nation of glycan sequence. In addition, ECD identifies
both halves of the ceramide and cleaves the acetyl moiety
to identify the presence of acetylated sugars. IRMPD of
both positive and negative ions produces extensive frag-
mentation, but requires multiple experiments at different
laser power, and also leads to secondary fragmentation,
whereas a single ECD experiment provides comparable or
more information. However, stepwise fragmentation by
IRMPD is useful tomap the relative lability among a series
of cleavages. Cleavage between the two halves of the
ceramide is seen by negative-ion (but not positive-ion)
IRMPD, although we do observe such cleavage by posi-
tive-ion IRMPD of sulfatides. EDD provides extensive
fragmentation of negative ions, but suffers from low
efficiency as well as complication of data analysis by
frequent hydrogen atom loss. Finally, mass defect analysis
can help to distinguish lipid from glycan from glycolipid
as an aid in assignment of MS/MS data.
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